The 11th International Conference of Radiopharmaceutical and Molecular Therapy (ICRT) was held in Kochi, Kerala, India, November 13–17, and was organized under the umbrella of the World Association of Radiopharmaceutical and Molecular Therapy (WARMTH) and in cooperation with the International Atomic Energy Agency. The meeting included presentations on various applications of radionuclides for therapy of cancer and other diseases.

On January 12, 2017 - the World Journal of Nuclear Medicine issue was made available online. To learn more about the Journal click here. To read the journal online click the image below.

We are pleased to announce the election results, and to both congratulate and extend a warm welcome to our new officers and members of our Advisory Board/Governing Body. Over 56% of eligible WARMTH Members took part in the election.

Based on the election results and Advisory Board appointments the 2016/17 WARMTH Leadership is as follows:

February, 2016

Dear Friends of WARMTH!

As the New Year 2016 has begun, I am looking forward to serving the WARMTH as its President for the two years (2016 /17). I greatly appreciate my predecessors (Richard Baum, the Late Ajit Padhy, and Harvey Turner) who have provided excellent examples of leadership of WARMTH. I am excited to have been a part of such exciting teams and working with the exceptional people instrumental in directing WARMTH, and thus my goal is to continue to maintain our phenomenal success.

Suresh Srivastava, Phd, President Elect of WARMTH and SNMMI Nuclear Oncology Council Vice President contributed an article for the spring 2014 NOC Newsletter. The article traces the history of WARMTH from the beginning in 2002 to our Society's goals for our ICRT events which are 1) To carry out an evaluation of the current status of radiopharmaceutical therapy on global basis; 2) To help in the transfer of important information on the current trends in radiopharmaceutical therapy from developed to developing countries; 3) To publish technical document based on the proceedings; 4) To promote radiopharmaceutical therapy on a global scale, particularly in developing countries; and 5) To formulate strategy documents for promoting the practice of radiopharmaceutical therapy around the world.

To read the entire article click here.